Avison Young Establishes Dedicated Global Life Sciences Real Estate Practice

In a strategic move to address the escalating and highly specialized real estate demands of the burgeoning life sciences sector, Avison Young has officially launched a new global specialty practice group. This dedicated team is designed to provide comprehensive, integrated real estate solutions to pharmaceutical, biotechnology, medical device, and related life sciences companies across key markets worldwide. The formation of this group underscores Avison Young’s commitment to delivering expert guidance and services in one of the most dynamic and technically intricate real estate segments.

Responding to the Explosive Growth in Life Sciences

The life sciences industry is currently experiencing unprecedented growth, fueled by rapid advancements in research and development, an aging global population, and increased investment in biotechnology and pharmaceuticals. This expansion translates directly into a surging demand for highly specialized real estate, including state-of-the-art laboratories, advanced manufacturing facilities, and secure research spaces. Companies in this sector require properties that not only meet stringent regulatory standards but also accommodate complex technical infrastructure and foster collaborative innovation. Traditional real estate approaches often fall short in addressing these unique requirements, making a specialized practice group an essential resource.

As Mark Rose, Chair and CEO of Avison Young, emphasizes, “The members of our new practice group possess a deep understanding of the entire pharmaceutical product life cycle. More critically, they are adept at navigating the intricate technical complexities that are inherent to life sciences real estate requirements. This specialized knowledge is crucial for mitigating potential budgetary overruns and scheduling risks, ensuring that our clients’ real estate strategies align perfectly with their scientific and business objectives.” This holistic perspective allows the team to foresee and address challenges that general real estate professionals might overlook, offering a significant advantage to clients.

A Global Network of Specialized Expertise

The newly formed Avison Young Life Sciences Specialty Practice Group is truly global in its scope and reach. It spans 10 key regional markets across the United States, Canada, Mexico, and Europe, reflecting the international nature of the life sciences industry. The group is comprised of 17 highly experienced Avison Young leasing professionals, each bringing a wealth of knowledge and a proven track record in serving life sciences clients. This geographical breadth ensures that whether a client needs a new research facility in Boston, a manufacturing plant in Ireland, or a lab expansion in San Diego, Avison Young has local experts who are also part of a globally coordinated team.

The company proudly states that the members of this new group are “industry veterans with decades of proven experience representing life science companies globally.” This extensive experience is not just about understanding market trends; it’s about a deep familiarity with the regulatory landscape, the specialized infrastructure requirements, and the financial models unique to the life sciences sector. This collective expertise allows Avison Young to offer unparalleled insights and strategic advice to its diverse client base.

Navigating the Technical and Operational Complexities

Life sciences facilities are unlike typical commercial properties. They demand specialized environments that can range from highly sterile laboratories to controlled vivariums for animal research, pilot plants for scaled-up production, and full-scale manufacturing facilities designed for specific biotechnological processes. Each of these facility types comes with its own set of critical technical specifications, including HVAC systems for precise environmental control, specialized plumbing and waste management, vibration-resistant flooring, and strict security protocols.

The Avison Young team is uniquely equipped to address the myriad risks associated with these complex requirements, focusing on all critical stages of project development:

Planning: Identifying suitable sites that meet specific scientific, logistical, and regulatory criteria.
Designing: Collaborating with architects and engineers to create efficient, flexible, and compliant lab and production spaces.
Engineering: Ensuring the integration of highly technical systems, from cleanrooms to specialized gas lines, meets performance benchmarks.
Construction: Overseeing the building process to ensure projects are delivered on time, within budget, and to exacting standards.

This integrated approach helps life sciences companies avoid costly delays, design flaws, and compliance issues that can significantly impact their research timelines and product development cycles.

Comprehensive Services Tailored for Life Sciences

Avison Young’s new life sciences practice group offers a holistic suite of services designed to support clients throughout every phase of their real estate journey. As CEO Mark Rose highlights, “This experience empowers us to seamlessly service all aspects of our clients’ real estate needs.” The breadth of services ensures that companies can rely on a single, expert partner for their entire portfolio, from initial concept to ongoing management:

Site Selection and Evaluation: Leveraging market intelligence and technical expertise to identify optimal locations that align with operational needs, workforce availability, and regulatory environments. This includes detailed analysis of infrastructure, zoning, and potential for future expansion.
Lease Negotiation: Crafting favorable lease agreements that not only secure competitive financial terms but also incorporate critical technical specifications, expansion options, and compliance requirements unique to life sciences.
Construction Management: Providing expert oversight of tenant improvements and new construction projects, ensuring adherence to strict timelines, budgets, and quality standards for specialized lab and manufacturing spaces.
Post-Lease Project Management: Offering ongoing support after occupancy, assisting with facility optimization, operational challenges, and strategic planning for future growth or portfolio adjustments. This long-term partnership ensures sustained efficiency and adaptability.

The Strategic Advantage: Integrating Technical and Financial Objectives

At the core of the group’s methodology is a unique focus on integrating each client’s precise technical and financial requirements directly into the lease-negotiation process. This is a critical differentiator. Unlike general commercial real estate negotiations, where technical specifications might be an afterthought, Avison Young prioritizes their inclusion from the outset. This ensures that every nuance, from the number of fume hoods to specific utility load capacities, is appropriately incorporated within transaction documents.

This meticulous process goes beyond mere transactional support. It actively fosters the development of innovative real estate strategies, underpinned by credible budgets and realistic schedules, especially during the early stages of transactions. By providing clients with thoroughly vetted facts and comprehensive analyses, Avison Young empowers them to make more fully informed decisions. This proactive approach minimizes unforeseen complications, reduces risks, and ultimately leads to more successful and sustainable real estate outcomes for life sciences firms.

Leadership and Market Insights

Guiding this dynamic new practice group is team leader Jerry Keeney, a principal and managing director of Avison Young’s San Diego office. With extensive experience in one of the world’s leading life sciences hubs, Keeney brings invaluable market perspective to the global initiative. He observes, “The life-sciences industry is expanding at a rapid pace, accounting for much of the leasing activity in markets such as San Francisco, Boston, and San Diego.” These particular markets are highlighted due to their established ecosystems of research institutions, talent pools, and venture capital, making them magnets for biotech innovation and, consequently, demand for specialized real estate.

Keeney emphasizes the importance of a global approach: “The launch of our partnership at the global level allows us to formulate cohesive solutions for our clients who often have operations in more than one location.” In an industry characterized by international collaboration, global supply chains, and multi-national R&D efforts, having a real estate partner capable of seamlessly supporting operations across borders is not just a convenience, but a strategic necessity. Avison Young’s integrated global network ensures consistency in service delivery and strategic planning, regardless of where a client’s facilities are located.

Avison Young’s Commitment to Innovation and Client Success

The establishment of the Life Sciences Specialty Practice Group is a testament to Avison Young’s forward-thinking approach and its commitment to anticipating and meeting the evolving needs of its clients. By creating a dedicated team of experts, the firm is positioning itself at the forefront of real estate services for one of the most critical and fast-growing sectors of the global economy. This initiative reflects a deep understanding that the future of real estate lies in specialization and client-centric solutions, especially for industries with such unique and demanding requirements.

Avison Young, with its headquarters located in Toronto, continues to strengthen its global presence and deepen its specialized expertise across various industries. The life sciences group is a prime example of how the firm leverages its talent and integrated service model to deliver exceptional value, helping clients not just find space, but truly optimize their operations and fuel their continued innovation and growth in a highly competitive landscape.